TY  - JOUR
TI  - Clinicopathological Features of Patients with Malignant Melanoma Diagnosis and Prognostic and Predictive Importance of Neuthrophil-Lymphocyte Ratio
AB  - In this study, the effect of demographic, laboratory and clinicopathological parameters along with neutrophil-lymphocyte ratio (NLR) on prognosis and survival and correlation with other parameters was researched in patients with malignant melanoma (MM) diagnosis. In our study, 107 patients monitored for MM diagnosis in Eskişehir Osmangazi University Medical Oncology clinic from 2010-2017 were retrospectively assessed. Age, gender, LDH level, pathological parameters, BRAF mutation status, neutrophil-lymphocyte ratio (NLR) and the effects of these parameters on overall survival (OS) and disease-free survival (DFS) and correlations with each other were researched. At time of diagnosis, 86% of patients were in the early stage. The dominant types identified were cutaneous MM and nodular MM. Median NLR cut-off value was identified as 1.97. All non-cutaneous MM cases were BRAF negative (p<0.0001). High NLR was associated with advanced stage (p=0.001), advanced age (p=0.008), ulceration presence (p=0.011), and high mitosis count (p=0.05). High NLR (p<0.0001), high LDH level (p=0.04), increased Breslow thickness (p=0.01), increased Clark level (p=0.01), high mitosis count (p=0.02), and lymph node (LN) involvement (p=0.04) were correlated with significantly shorter OS durations. Cox multivariate regression analysis identified the most effective independent parameters on OS were LN involvement (HR: 3.4, p=0.01) and high NLR (HR: 4.6, p=0.04). Nodal involvement was also identified as the most predictive independent parameter for recurrence (HR: 3.2, p=0.03). In addition to classic parameters, NLR appears to be a biomarker which can predict prognosis. Patients with nodal involvement and high NLR values should be monitored more closely in clinics. Data require support with broad-scale studies.
AU  - SAĞDIÇ KARATEKE, Yasemin
AU  - Demir, Lütfiye
AU  - Dincer, Murat
AU  - Yildiz, Bulent
DO  - 10.20515/otd.1226498
PY  - 2023
JO  - Osmangazi Tıp Dergisi
VL  - 45
IS  - 5
SN  - 1305-4953
SP  - 651
EP  - 664
DB  - TRDizin
UR  - http://search/yayin/detay/1198754
ER  -